• Bifendate (DDB): Mechanistic Leverage for Next-Gen Hepatopro

  2026-06-03

  This article delivers strategic guidance for translational researchers by integrating the latest mechanistic insights into Bifendate (DDB), a synthetic Schisandrin C derivative. It examines DDB’s role in hepatoprotection, lipid metabolism regulation, and autophagy inhibition, contextualized by competitive pharmacology and P450 modulation. The discussion bridges bench-to-bedside translation, grounded in robust evidence and practical protocol design, while highlighting APExBIO’s leadership in high-integrity research tools.

• TK1 Expression in Uterine Corpus Endometrial Carcinoma: Insi

  2026-06-03

  This article reviews a recent comprehensive analysis of thymidine kinase 1 (TK1) in uterine corpus endometrial carcinoma (UCEC), highlighting the gene's upregulation, prognostic value, and its role in cell cycle and DNA replication. The findings support TK1 as a potential biomarker for diagnosis and therapy monitoring in UCEC, with implications for cell proliferation research.

• Merimepodib (VX-497): Advanced Protocols for Antiviral Resea

  2026-06-02

  Merimepodib (VX-497) offers researchers a precision tool to dissect guanine nucleotide metabolism, serving as a powerful IMPDH inhibitor with broad applications in antiviral, immunosuppressive, and cancer research. This article translates cutting-edge findings into actionable protocols, workflow enhancements, and troubleshooting strategies that maximize the scientific impact of Merimepodib in the laboratory.

• Sodium Picosulfate in GI Research: Protocols and Troubleshoo

  2026-06-02

  Sodium Picosulfate uniquely enables researchers to fine-tune water and electrolyte flux in gastrointestinal models, advancing both chronic and opioid-induced constipation studies. This guide translates recent neuroinflammation imaging breakthroughs into actionable workflows, troubleshooting, and cross-domain applications for gut–liver–brain axis research.

• Corynoline Induces Mitochondrial Apoptosis via Src/JNK in Os

  2026-06-01

  The referenced study demonstrates that Corynoline, a natural isoquinoline alkaloid, exerts anti-osteosarcoma effects by inducing G2/M cell cycle arrest and promoting mitochondrial apoptosis through Src/JNK pathway activation. These findings highlight a promising mechanistic target for osteosarcoma treatment and inform future cell death analysis workflows.

• Asunaprevir (BMS-650032): Applied Workflows for HCV Inhibiti

  2026-06-01

  Asunaprevir (BMS-650032) stands out as a potent, broad-spectrum inhibitor of HCV NS3 protease, enabling robust inhibition across multiple genotypes and cell systems. This article details practical workflows, troubleshooting strategies, and advanced applications that maximize the translational value of Asunaprevir in antiviral research.

• Cabozantinib (XL184) in RCC: Protocols, Adaptation & Trouble

  2026-05-31

  Cabozantinib (XL184) enables advanced, timescale-dependent dissection of kinase signaling and antiangiogenic adaptation in renal cell carcinoma models. This guide translates phosphoproteomic insights into actionable protocols, troubleshooting strategies, and comparative research advantages for robust kinase inhibitor studies.

• Cell Counting Kit-8 (CCK-8): Precision in Immunometabolic As

  2026-05-30

  Uncover how the Cell Counting Kit-8 (CCK-8) enables precise cell proliferation and cytotoxicity measurement in immunometabolism, with advanced insights grounded in new asthma research. Discover why CCK-8 is pivotal for cell viability assays in translational studies.

• HyperTrap Heparin HP Column: Precision Purification for Stem

  2026-05-29

  The HyperTrap Heparin HP Column delivers unmatched selectivity and resolution for isolating key signaling mediators from complex biological samples. Its advanced HyperChrom Heparin HP Agarose matrix enables researchers to dissect cancer stem cell pathways, such as CCR7–Notch1 crosstalk, with reproducibility and workflow efficiency that outpaces conventional affinity columns.

• ARCA EGFP mRNA (5-moUTP): Advancing Polyadenylated mRNA Assa

  2026-05-29

  ARCA EGFP mRNA (5-moUTP) sets a new benchmark for polyadenylated mRNA reporter assays by combining high translational efficiency with robust immune evasion. Its advanced capping and 5-moUTP modification streamline fluorescence-based transfection control, enabling reproducible, low-noise detection in mammalian systems.

• PXR Activation by Pregnenolone-16α-carbonitrile Inhibits Hep

  2026-05-28

  This study demonstrates that activation of the pregnane X receptor (PXR) by pregnenolone-16α-carbonitrile (PCN) significantly protects against cholestatic liver injury by inhibiting both canonical and non-canonical pyroptosis in hepatocytes. The findings introduce a mechanistic framework for targeting PXR in hepatic detoxification and highlight new therapeutic avenues against cholestatic pathology.

• Monomethyl Auristatin E (MMAE): Shaping Tumor Plasticity in

  2026-05-28

  Explore how Monomethyl auristatin E (MMAE) uniquely empowers targeted cancer therapy by modulating tumor cell plasticity, with insights into its mechanism, protocol parameters, and translational potential. This in-depth article reveals new perspectives for antibody-drug conjugate payload selection.

• Targeting Tau Ser356 Phosphorylation in Alzheimer's: NUAK In

  2026-05-27

  Taylor et al. (2023) reveal that phosphorylation of tau at serine 356 is closely linked to Alzheimer’s disease progression and can be selectively reduced in human and mouse brain tissue using NUAK kinase inhibition. Their ex vivo experiments highlight both the pathological prominence of p-tau Ser356 and the differential response of mouse versus human tissue to targeted kinase inhibition, informing future therapeutic strategies.

• Merimepodib (VX-497): Selective Oral IMPDH Inhibitor in Rese

  2026-05-27

  Merimepodib (VX-497) is a selective, orally bioavailable inhibitor of inosine monophosphate dehydrogenase (IMPDH), disrupting guanine nucleotide biosynthesis and cellular proliferation. It demonstrates potent antiviral, immunosuppressive, and anticancer activity in vitro and in vivo. This article compiles atomic, evidence-backed claims and protocol guidance for research use.

• Multi-Omics Uncovers ARID1A-Driven Resistance in Melanoma

  2026-05-26

  This study integrates multi-omics to map drug response and resistance networks in BRAF-mutant melanoma, identifying ARID1A loss as a key driver of resistance to BRAF/MAPK inhibitors. The findings reveal actionable resistance nodes and signaling rewiring, offering new targets for improving the durability of melanoma therapies.

16649 records 1/1110 page Next 12345 下5页 Last page